|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
T
Tagum, Philippines, 2003, Vol. 17(1) pp. 7
Takacs, Beckie, 1998, Vol. 12(4) pp. 7
Takahashi, O., 1989, Vol. 03(2) pp. 1
Takarae, Yukari, 2004, Vol. 18(3) pp. 4
"talking head," 2001, Vol. 15(4) pp. 5
Talking Mitt, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
Talking Typewriter, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
Tallal, Paula, 1995, Vol. 09(4) pp. 2; 1997, Vol. 11(4) pp. 1.
Tallis, Frank, 1995, Vol. 09(3) pp. 4
Talvik, T., 1996, Vol. 10(1) pp. 2
tandem bicycling, 1989, Vol. 03(4) pp. 7
Tanguay, Peter, 1991, Vol. 05(2) pp. 2
Tani, Yoshihiro, 1997, Vol. 11(4) pp. 4
Tanoue, Yoko, 1988, Vol. 02(3) pp. 4
Tantam, Digby, 1988, Vol. 02(4) pp. 7; 1995, Vol. 09(2) pp. 6.
tantrums
drugs (buspirone) for, 1991, Vol. 05(4) pp. 4
drugs (carbamazepine) for, 1990, Vol. 04(2) pp. 2
drugs (clomipramine) for, 1993, Vol. 07(3) pp. 1
drugs (fluoxetine) for, 1991, Vol. 05(2) pp. 4; 1991, Vol. 05(4) pp. 1; 1992, Vol. 06(3) pp. 4; 1998, Vol. 12(4) pp. 1; 1999, Vol. 13(2) pp. 2.
drugs (lamotrigine) for, 1998, Vol. 12(2) pp. 5
drugs (lithium) for, 1989, Vol. 03(3) pp. 4
drugs (naltrexone) for, 1989, Vol. 03(3) pp. 1; 1991, Vol. 05(3) pp. 4.
from food coloring, 2002, Vol. 16(4) pp. 7
mood music for, 1998, Vol. 12(1) pp. 5
neurofeedback therapy for, 2003, Vol. 17(1) pp. 2
from pain, 2003, Vol. 17(1) pp. 7
peptides and, 1991, Vol. 05(4) pp. 2
secretin for, 1999, Vol. 13(1) pp. 3
social stories for, 2002, Vol. 16(2) pp. 6–7
supplements (DMG) for, 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(3) pp. 2; 1995, Vol. 09(2) pp. 7.
supplements (folic acid) for, 1993, Vol. 07(4) pp. 6; 1995, Vol. 09(2) pp. 7.
supplements (magnesium) for, 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(3) pp. 2.
supplements (melatonin) for, 1994, Vol. 08(3) pp. 1–2
supplements (omega-3-fatty acids) for, 1999, Vol. 13(1) pp. 7
supplements (vitamin B6) for, 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(3) pp. 2.
Tapson, Victor, 2000, Vol. 14(4) pp. 4
Taras, Marie, 1988, Vol. 02(3) pp. 3
tardive akathisia, 1992, Vol. 06(2) pp. 7; 1999, Vol. 13(3) pp. 2; 2003, Vol. 17(4) pp. 4.
tardive dyskinesia (TD). See also dyskinesia
drugs and elderly autistics, 1990, Vol. 04(2) pp. 3–4
drugs (antidepressant) and, 1992, Vol. 06(1) pp. 5; 1996, Vol. 10(4) pp. 7; 1997, Vol. 11(1) pp. 4.
drugs (haloperidol) and, 1990, Vol. 04(1) pp. 1; 1996, Vol. 10(4) pp. 7.
drugs (naltrexone) for, 1992, Vol. 06(2) pp. 2
drugs (risperidone) and, 1994, Vol. 08(4) pp. 1; 1997, Vol. 11(2) pp. 7; 1997, Vol. 11(3) pp. 2; 1998, Vol. 12(3) pp. 1; 2002, Vol. 16(4) pp. 6.
drugs (Tarvil) and, 2003, Vol. 17(3) pp. 6
drugs (ziprazidone) and, 2004, Vol. 18(1) pp. 6
and free radicals, 1996, Vol. 10(2) pp. 5
melatonin for, 2001, Vol. 15(4) pp. 6
and respiratory dyskinesia, 1995, Vol. 09(2) pp. 4
vitamin B6 for, 1992, Vol. 06(2) pp. 7; 1999, Vol. 13(3) pp. 2; 2003, Vol. 17(4) pp. 4.
vitamin C for, 1992, Vol. 06(2) pp. 7
vitamin E for, 1991, Vol. 05(1) pp. 5; 1992, Vol. 06(2) pp. 7; 1994, Vol. 08(3) pp. 1; 1996, Vol. 10(2) pp. 5; 1996, Vol. 10(4) pp. 7; 1998, Vol. 12(3) pp. 5; 1998, Vol. 12(4) pp. 6.
tardive parkinsonism, 1999, Vol. 13(3) pp. 2
"Target Symptom Behavior Checklist," 2000, Vol. 14(3) pp. 3
Tarnopolsky, Mark, 1999, Vol. 13(3) pp. 4
Tarr, Michael, 2000, Vol. 14(2) pp. 6
Tarsy, Daniel, 1996, Vol. 10(3) pp. 2
tartrazine, 1995, Vol. 09(2) pp. 5
Tarvil, 2003, Vol. 17(3) pp. 6
TASH (The Association for Persons with Severe Disabilities), 1990, Vol. 04(3) pp. 7; 1991, Vol. 05(3) pp. 3; 1994, Vol. 08(1) pp. 1; 1996, Vol. 10(2) pp. 3.
Task Demonstration Model (TDM), 1991, Vol. 05(3) pp. 5
task modification, 1994, Vol. 08(1) pp. 2
task variation, 1987, Vol. 01(3) pp. 5; 1989, Vol. 03(2) pp. 5; 1990, Vol. 04(3) pp. 6; 1993, Vol. 07(1) pp. 5; 1998, Vol. 12(4) pp. 5.
Tatum, W. O., 2001, Vol. 15(2) pp. 7
Tay Sachs, 1995, Vol. 09(2) pp. 4
Taylor, Brent, 2002, Vol. 16(1) pp. 6
Taylor, Bridget A., 1999, Vol. 13(2) pp. 5; 2004, Vol. 18(2) pp. 5.
Taylor, D.V., 1992, Vol. 06(1) pp. 2
Taylor, L. H., 2001, Vol. 15(1) pp. 5
Taylor, Terri, 1997, Vol. 11(2) pp. 6
TD. See tardive dyskinesia
tea, green, 2002, Vol. 16(4) pp. 5
TEACCH, 1994, Vol. 08(4) pp. 2. See also Schopler
Teachers Association of Baltimore County, 1993, Vol. 07(4) pp. 2
Teaching a Mute Autistic Boy to Read (Hewett), 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
Teaching Developmentally Disabled Children: The Me Book, (Pro Ed Publishers), 1993, Vol. 07(1) pp. 1
"Teaching Reading to a Mute Autistic Boy Through Operant Conditioning" (article, Hewett), 1992, Vol. 06(3) pp. 3
Teebi, Ahmad S., 1989, Vol. 03(4) pp. 4; 1990, Vol. 04(1) pp. 4.
Tegretol. See carbamazepine (Tegretol)
Teicher, Martin, 1990, Vol. 04(3) pp. 7
Teitelbaum, Osnat, 2004, Vol. 18(3) pp. 5
Teitelbaum, Philip, 1999, Vol. 13(1) pp. 1; 1999, Vol. 13(2) pp. 7; 2004, Vol. 18(3) pp. 5.
telepathy, 1993, Vol. 07(1) pp. 3
temper outbursts. See tantrums
temporal lobe seizures, 1993, Vol. 07(1) pp. 4; 2001, Vol. 15(2) pp. 7; 2003, Vol. 17(3) pp. 4.
temporal lobes
amygdala defects in high-functioning autistics, 2000, Vol. 14(4) pp. 2; 2001, Vol. 15(4) pp. 1.
bilateral damage and Landau-Kleffner, 1991, Vol. 05(1) pp. 2
cell column defects in, 2002, Vol. 16(1) pp. 1
cysts in, 1987, Vol. 01(4) pp. 7
epilepsy of, 1997, Vol. 11(3) pp. 4
hypofusion in, 2001, Vol. 15(1) pp. 6
lesions in Landau-Kleffner, 1991, Vol. 05(1) pp. 2
seizures and self-injuring behaviors, 1993, Vol. 07(1) pp. 4
surgery for seizures, 1996, Vol. 10(3) pp. 5
tumors and autistic symptoms, 1992, Vol. 06(3) pp. 4; 1997, Vol. 11(1) pp. 4.
TenNapel, Scott, 1988, Vol. 02(3) pp. 8
Terai, K., 1999, Vol. 13(2) pp. 4
terbutaline, 2004, Vol. 18(3) pp. 6; 2004, Vol. 18(4) pp. 7.
Tesh, Robert M., 1994, Vol. 08(2) pp. 6
testosterone, 1988, Vol. 02(2) pp. 7; 1998, Vol. 12(4) pp. 7; 2001, Vol. 15(2) pp. 5; 2002, Vol. 16(3) pp. 6.
tetanolysin, 1998, Vol. 12(4) pp. 6
tetanus, 1998, Vol. 12(4) pp. 1; 1999, Vol. 13(1) pp. 7.
tetrahydocannabinol (THC), 2003, Vol. 17(1) pp. 3–4. See also cannabinoids
tetrahydrobiopterin. See R-THBP
thalamus, 1996, Vol. 10(1) pp. 5; 1997, Vol. 11(4) pp. 4; 1999, Vol. 13(3) pp. 7; 2001, Vol. 15(3) pp. 4.
thalidomide, 1997, Vol. 11(3) pp. 1; 1998, Vol. 12(1) pp. 5.
THC (tetrahydocannabinol), 2003, Vol. 17(1) pp. 3; 2003, Vol. 17(4) pp. 4. See also marijuana, Marinol
Theories of Autism: Case Studies in Autism; Holistic Interpretation of Autism (Seifert), 1991, Vol. 05(2) pp. 7; 1991, Vol. 05(2) pp. 7.
theory of mind
and aggression, 1998, Vol. 12(4) pp. 6
and amygdala damage, 2001, Vol. 15(4) pp. 1; 2004, Vol. 18(2) pp. 2.
anxiety and lack of, 1998, Vol. 12(4) pp. 6
in Asperger siblings, 2004, Vol. 18(1) pp. 5
and brain abnormalities, 1995, Vol. 09(1) pp. 4; 1995, Vol. 09(3) pp. 4; 2001, Vol. 15(3) pp. 4; 2001, Vol. 15(4) pp. 1.
and conversation, 2002, Vol. 16(3) pp. 6
and eye contact, 1993, Vol. 07(2) pp. 4; 1996, Vol. 10(1) pp. 6; 2002, Vol. 16(3) pp. 6.
gender differences in, 2002, Vol. 16(3) pp. 6
prosthetic devices, 1998, Vol. 12(4) pp. 6–7
and social deficits, 1987, Vol. 01(4) pp. 1; 1990, Vol. 04(2) pp. 2; 1993, Vol. 07(2) pp. 4; 1996, Vol. 10(1) pp. 6; 1997, Vol. 11(1) pp. 7; 1998, Vol. 12(4) pp. 6.
virtual reality for teaching, 2002, Vol. 16(3) pp. 5
and vocabulary, 2002, Vol. 16(3) pp. 6
There's a Boy in Here (Barron and Barron), 1992, Vol. 06(2) pp. 7
thiamine (vitamin B1), 1990, Vol. 04(1) pp. 2; 2002, Vol. 16(3) pp. 4.
thiazide diuretics, 2004, Vol. 18(1) pp. 5
Thierman, Katy, 2002, Vol. 16(4) pp. 4
thimerosol
and autoimmunity, 2004, Vol. 18(1) pp. 6; 2004, Vol. 18(4) pp. 4.
ban sought, 2000, Vol. 14(4) pp. 7; 2001, Vol. 15(2) pp. 1; 2004, Vol. 18(1) pp. 9.
bolus dose, 2003, Vol. 17(2) pp. 1
CA. ban, 2004, Vol. 18(3) pp. 1
CDC (Center for Disease Control) coverup on, 2001, Vol. 15(3) pp. 9; 2001, Vol. 15(4) pp. 1; 2002, Vol. 16(2) pp. 1.
and cellular damage, 2003, Vol. 17(3) pp. 1
and cerebellar granule neurons, 2003, Vol. 17(4) pp. 1
and epidemic of autism, 2002, Vol. 16(3) pp. 3; 2004, Vol. 18(3) pp. 3.
FDA's "incremental approach" to removal of, 2003, Vol. 17(2) pp. 1–2
gender and risk, 2003, Vol. 17(2) pp. 2
genetic damage from, 2003, Vol. 17(1) pp. 2
glutathione and, 2003, Vol. 17(1) pp. 2; 2004, Vol. 18(4) pp. 1.
heart disease from, 2003, Vol. 17(1) pp. 1–2
injections and oral ingestion compared, 2003, Vol. 17(1) pp. 1
labeling problem, 2001, Vol. 15(3) pp. 1; 2004, Vol. 18(1) pp. 9.
and language delay, 2003, Vol. 17(4) pp. 7
and methylation, 2004, Vol. 18(1) pp. 1; 2004, Vol. 18(4) pp. 1.
and neurotoxicity, 2004, Vol. 18(2) pp. 1
in RhoGam shots, 2003, Vol. 17(1) pp. 7
safety, 2002, Vol. 16(4) pp. 1; 2004, Vol. 18(2) pp. 3.
and speech disorders, 2003, Vol. 17(4) pp. 2
and tics, 2003, Vol. 17(4) pp. 7
in vaccines, 1999, Vol. 13(3) pp. 1; 2000, Vol. 14(2) pp. 7; 2000, Vol. 14(3) pp. 1; 2002, Vol. 16(3) pp. 1; 2002, Vol. 16(4) pp. 1; 2003, Vol. 17(2) pp. 1; 2003, Vol. 17(4) pp. 2; 2004, Vol. 18(3) pp. 1; 2004, Vol. 18(4) pp. 2.
"thinking" test, 1996, Vol. 10(1) pp. 6
thioridazine (Mellaril), 1991, Vol. 05(4) pp. 4; 2000, Vol. 14(4) pp. 4; 2003, Vol. 17(4) pp. 5.
Thomas, Glyn V., 1989, Vol. 03(2) pp. 5
Thomas, Mandy, 1998, Vol. 12(3) pp. 6
Thomas, Marshall, 1996, Vol. 10(4) pp. 7; 1997, Vol. 11(1) pp. 4.
Thomas, N. Simon, 1999, Vol. 13(3) pp. 5
Thompson, C., 1999, Vol. 13(1) pp. 4
Thornburgh, Governor, 1994, Vol. 08(1) pp. 6
Thorpe, Joanne, 1993, Vol. 07(1) pp. 5
Thorwarth, Carolyn, 1991, Vol. 05(3) pp. 5
"thought bubbles," 2002, Vol. 16(3) pp. 5
Thys-Jacobs, Susan, 1998, Vol. 12(3) pp. 6
tics. See also Tourette's
cannabinoids for, 2002, Vol. 16(2) pp. 7; 2003, Vol. 17(1) pp. 4.
as common, 2001, Vol. 15(4) pp. 5
from mercury poisoning, 2000, Vol. 14(3) pp. 1; 2003, Vol. 17(4) pp. 7.
strep and, 2002, Vol. 16(1) pp. 4
Tierney, David W., 1988, Vol. 02(3) pp. 5
tilting test, 2004, Vol. 18(3) pp. 5
time delay, 1987, Vol. 01(2) pp. 5; 1988, Vol. 02(2) pp. 6.
time-outs, 1989, Vol. 03(1) pp. 5; 1989, Vol. 03(4) pp. 6; 1994, Vol. 08(2) pp. 5.
"timeout ribbon" technique, 2002, Vol. 16(2) pp. 5
Tinbergen, Nikolas, 1987, Vol. 01(3) pp. 3; 1989, Vol. 03(1) pp. 6.
tinnitus, 1998, Vol. 12(3) pp. 7
Todd, Brian, 1995, Vol. 09(3) pp. 7
Todd, Richard, 1987, Vol. 01(2) pp. 2; 1988, Vol. 02(2) pp. 4.
toe walking, 1993, Vol. 07(3) pp. 6; 2000, Vol. 14(3) pp. 1.
Toenniessen, L.M., 1990, Vol. 04(2) pp. 4
toilet training, 1994, Vol. 08(1) pp. 7; 1995, Vol. 09(3) pp. 2; 1998, Vol. 12(2) pp. 7; 1998, Vol. 12(3) pp. 3; 1999, Vol. 13(1) pp. 3.
Tolbert, Lelland, 1992, Vol. 06(1) pp. 4; 1997, Vol. 11(4) pp. 3.
Tomatis, Alfred, 1990, Vol. 04(4) pp. 3
Tomatis Listening Centers, 1990, Vol. 04(4) pp. 3; 1991, Vol. 05(3) pp. 2.
Tommey, Billy, 1999, Vol. 13(3) pp. 2
Tommey, Polly, 1999, Vol. 13(3) pp. 2
Tomporowski, Phillip, 1989, Vol. 03(1) pp. 7
tooth grinding, 1988, Vol. 02(4) pp. 5; 1992, Vol. 06(1) pp. 4; 1993, Vol. 07(3) pp. 6.
Topcu, Meral, 1991, Vol. 05(3) pp. 4
Torrente, F., 2002, Vol. 16(2) pp. 1
total serum protein (TSP), 2002, Vol. 16(4) pp. 4
Toth, M., 2001, Vol. 15(3) pp. 4
touch therapy, 1987, Vol. 01(3) pp. 3; 1997, Vol. 11(3) pp. 5.
Touching (Montagu), 1987, Vol. 01(3) pp. 3
Tourette's Syndrome
alcohol for, 1998, Vol. 12(2) pp. 7
and anxiety, 1991, Vol. 05(3) pp. 1
asthma mistaken for, 1999, Vol. 13(3) pp. 4
autism link, 1988, Vol. 02(1) pp. 1; 1991, Vol. 05(3) pp. 1.
behavior modification and, 1988, Vol. 02(2) pp. 6; 1988, Vol. 02(3) pp. 6; 1994, Vol. 08(2) pp. 5; 2003, Vol. 17(2) pp. 5.
and bipolar disorder, 1988, Vol. 02(1) pp. 1
botulinum for, 2000, Vol. 14(3) pp. 4
and cardiac arrhythmias, 2000, Vol. 14(1) pp. 4
clonidine for, 1992, Vol. 06(3) pp. 2
co-morbid conditions, 1990, Vol. 04(3) pp. 5; 1991, Vol. 05(3) pp. 1.
and depression, 1991, Vol. 05(3) pp. 1; 2002, Vol. 16(4) pp. 7.
desipramine for, 1995, Vol. 09(3) pp. 4
and dopamine, 1992, Vol. 06(2) pp. 4; 1998, Vol. 12(2) pp. 7.
foreboding feelings, 2000, Vol. 14(3) pp. 4
frontal cortical damage in, 1990, Vol. 04(3) pp. 5
"habit reversal" for, 2003, Vol. 17(2) pp. 5
and herpes simplex, 1997, Vol. 11(2) pp. 2
high rates of, 2001, Vol. 15(4) pp. 5
intravenous gamma globulin (IVIG) therapy for, 1996, Vol. 10(3) pp. 1
and IQ, 1987, Vol. 01(3) pp. 4
Latitudes (newsletter), 1994, Vol. 08(2) pp. 6
and Lyme disease, 2000, Vol. 14(2) pp. 4
marijuana for, 1998, Vol. 12(2) pp. 7; 2002, Vol. 16(2) pp. 7.
mecamylamine for, 1998, Vol. 12(4) pp. 2
and Mycoplasma pneumoniae, 2000, Vol. 14(2) pp. 4
newsletter on alternative therapies, 1994, Vol. 08(2) pp. 6
nicotine for, 1998, Vol. 12(2) pp. 1; 1998, Vol. 12(4) pp. 2.
and OCD, 1991, Vol. 05(3) pp. 1; 1995, Vol. 09(4) pp. 4.
and pimozide (ORAP), 2000, Vol. 14(1) pp. 4
prevalence of, 1990, Vol. 04(3) pp. 5
Prozac for, 1991, Vol. 05(4) pp. 1
and risperidone, 1995, Vol. 09(4) pp. 4; 1997, Vol. 11(2) pp. 7; 2002, Vol. 16(4) pp. 7.
and seizures, 1991, Vol. 05(3) pp. 2; 1992, Vol. 06(1) pp. 4; 1995, Vol. 09(4) pp. 3.
and serotonin, 1990, Vol. 04(3) pp. 5; 1991, Vol. 05(3) pp. 2.
and strep, 1996, Vol. 10(3) pp. 1; 1997, Vol. 11(2) pp. 2; 1998, Vol. 12(2) pp. 2; 2002, Vol. 16(1) pp. 4.
surgery for, 1995, Vol. 09(2) pp. 1–2
tetrahydrocannabinol (Delta (9)-THC) for, 2003, Vol. 17(1) pp. 4
and tryptophan, 1991, Vol. 05(3) pp. 2
toxic psychosis, 2003, Vol. 17(1) pp. 5
toxics
and ADHD increase, 2000, Vol. 14(3) pp. 1
aluminum, 2000, Vol. 14(4) pp. 3; 2001, Vol. 15(2) pp. 1; 2002, Vol. 16(3) pp. 2; 2003, Vol. 17(1) pp. 4.
antimony, 2002, Vol. 16(3) pp. 2
arsenic, 2002, Vol. 16(3) pp. 4
and autism increase, 1995, Vol. 09(3) pp. 3; 2000, Vol. 14(3) pp. 1.
birth defects monitoring program's findings, 2000, Vol. 14(2) pp. 6
bisphenol A (BPA), 2003, Vol. 17(2) pp. 6
cadmium, 2002, Vol. 16(3) pp. 4
fluoridation methods, 1998, Vol. 12(4) pp. 5
formaldehyde, 1995, Vol. 09(1) pp. 7; 2000, Vol. 14(4) pp. 3; 2001, Vol. 15(2) pp. 1.
general discussion, 1998, Vol. 12(1) pp. 3
glutathione and, 2004, Vol. 18(4) pp. 1
hair sample anomaly, 2002, Vol. 16(2) pp. 3; 2003, Vol. 17(2) pp. 4.
landfills and chromosome abnormalities, 2002, Vol. 16(1) pp. 4
lead, 1994, Vol. 08(1) pp. 5; 1995, Vol. 09(3) pp. 5; 1995, Vol. 09(4) pp. 7; 1998, Vol. 12(4) pp. 5; 2002, Vol. 16(3) pp. 4.
Leominster, 1990, Vol. 04(4) pp. 6; 1992, Vol. 06(2) pp. 1; 1993, Vol. 07(3) pp. 5; 1994, Vol. 08(1) pp. 4.
and liver detoxification defects in autistics, 1998, Vol. 12(3) pp. 2
mercury (See mercury)
in metallothionein disorder, 2001, Vol. 15(2) pp. 4
nickel, 2002, Vol. 16(3) pp. 4
organophosphates, 2003, Vol. 17(1) pp. 6
"Polluting our Future" report, 2000, Vol. 14(3) pp. 1
and premature births, 2000, Vol. 14(3) pp. 1
Prevent Autism Now, 1994, Vol. 08(3) pp. 6
and purine-metabolic impairment, 2001, Vol. 15(1) pp. 2
streptokinase, 2003, Vol. 17(4) pp. 4
TTFD (thiamine tetrahydrofurfuryl disulfide) for removing, 2002, Vol. 16(3) pp. 4
vitamin C to protect against, 1998, Vol. 12(2) pp. 3; 2000, Vol. 14(1) pp. 5.
training. See education
Tranebjaerg, Lisbeth, 1991, Vol. 05(3) pp. 4
transcutaneous electrical nerve stimulation (TENS)
transfer factor therapy, 1997, Vol. 11(2) pp. 1
transitioning, 1997, Vol. 11(1) pp. 6; 1998, Vol. 12(4) pp. 1.
Trauner, Doris, 1988, Vol. 02(2) pp. 4
trazodone, 1992, Vol. 06(1) pp. 5; 2002, Vol. 16(2) pp. 7.
treatment efficacy scales, 1999, Vol. 13(4) pp. 2
Treffert, Darold A., 1989, Vol. 03(1) pp. 1; 1989, Vol. 03(4) pp. 7; 2003, Vol. 17(2) pp. 7; 2003, Vol. 17(3) pp. 6.
Trelka, Jeffrey Allen, 2004, Vol. 18(4) pp. 2
tremors, 1999, Vol. 13(3) pp. 4; 2000, Vol. 14(4) pp. 4; 2002, Vol. 16(3) pp. 4.
Trexan. See naltrexone
TRH loading tests, 1987, Vol. 01(4) pp. 7
"Triangle of Choices," 1997, Vol. 11(4) pp. 5
trichotillomania (hair pulling), 1991, Vol. 05(2) pp. 4; 1991, Vol. 05(4) pp. 4.
Trident gum, 2000, Vol. 14(3) pp. 6
Trigger List", 1996, Vol. 10(1) pp. 7
Trimble, Michael, 1999, Vol. 13(3) pp. 4
trinucleotide sequences, 1996, Vol. 10(4) pp. 5
triple vaccines, 2001, Vol. 15(2) pp. 3; 2001, Vol. 15(3) pp. 3. See also vaccines, individual triple vaccines
Truss, C. Orian, 1989, Vol. 03(1) pp. 6
tryptophan
and 5-HTP, 1999, Vol. 13(1) pp. 2
depletion consequences, 1993, Vol. 07(3) pp. 2; 1996, Vol. 10(4) pp. 6; 1999, Vol. 13(4) pp. 4.
and developmental quotient, 1987, Vol. 01(4) pp. 6
FDA ban, 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 7; 1994, Vol. 08(1) pp. 3; 1996, Vol. 10(4) pp. 6.
and large neutral amino acids (LNAAs), 1996, Vol. 10(1) pp. 6
for Rett's treatment, 1990, Vol. 04(4) pp. 4
and serotonin, 1996, Vol. 10(1) pp. 6; 1996, Vol. 10(4) pp. 6; 1997, Vol. 11(4) pp. 4.
Tourette levels of, 1991, Vol. 05(3) pp. 2
Wright lawsuit about, 1992, Vol. 06(2) pp. 3
TSP (total serum protein), 2002, Vol. 16(4) pp. 4
TTFD (thiamine tetrahydrofurfuryl disulfide), 2002, Vol. 16(3) pp. 4
tuberous sclerosis
autism link, 1987, Vol. 01(2) pp. 4; 1993, Vol. 07(3) pp. 4; 1995, Vol. 09(4) pp. 3; 1996, Vol. 10(2) pp. 7; 1996, Vol. 10(3) pp. 5.
genetics compared to autism's, 1989, Vol. 03(2) pp. 6
tuber damage and autism, 1997, Vol. 11(1) pp. 4; 2001, Vol. 15(4) pp. 4.
tubers, 1997, Vol. 11(1) pp. 4
tumor necrosis factor-alpha, 1997, Vol. 11(1) pp. 2
Turek, S., 1997, Vol. 11(1) pp. 2
Turkel, Henry, 1992, Vol. 06(3) pp. 2
Turkeltaub, P.E., 2004, Vol. 18(1) pp. 5
Turner, Leyla, 2003, Vol. 17(1) pp. 5
Turner's syndrome, 2001, Vol. 15(1) pp. 5
Turning Lead Into Gold (Hallaway and Strauts), 1995, Vol. 09(3) pp. 5; 1995, Vol. 09(4) pp. 7.
Turuba, Renelle, 1994, Vol. 08(4) pp. 7
Tutin, Judith, 1996, Vol. 10(1) pp. 7
twins, 1989, Vol. 03(2) pp. 1; 1997, Vol. 11(2) pp. 4; 2001, Vol. 15(4) pp. 5.
two-trainer therapy model, 2001, Vol. 15(1) pp. 6
Tylenol products, 2003, Vol. 17(1) pp. 5
tympanostomy, 1994, Vol. 08(4) pp. 1
tyrosine, 1990, Vol. 04(4) pp. 4; 2002, Vol. 16(1) pp. 7.
© copyright 2005, 2006 Autism Research Institute
|
|
